Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dirk Evers, David Ghesquiere

Premium

Dirk Evers is VP of data operations at Molecular Health in Heidelberg, Germany. Previously, he was senior VP of informatics at the New York Genome Center and also served as the director of computational biology at Illumina. He holds a PhD in bioinformatics from Bielefeld University.


NanoString Technologies has appointed David Ghesquiere as senior VP of corporate and business development. Ghesquiere joins NanoString from Dendreon, where he served as senior VP of corporate and business development. He has also served executive roles with OSI Pharmaceuticals (acquired by Astellas) and Aventis Pharmaceuticals (acquired by Sanofi).

Filed under

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.